archiveConferences

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will participate in the following upcoming healthcare conferences: Investment ConferencesJefferies Global Healthcare Conference (New York)   Presentation Thursday, June 5, 9:20 AM ET + 1x1 meetingsSachs European BioPharma Obesity Innovation Forum   Next Gen Therapeutics Panel + presentation + 1x1 meetings, Wednesday, June 11 Get the latest news delivered to your inbox Sign up for...

LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at two upcoming virtual investment conferences. Event:   Lytham Partners Spring 2025 Investor ConferenceType:   Fireside Chat Date/Time:   Thursday, May 29, 2025, at 12:30 p.m. ETEvent:   Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference Get the latest news delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address,...